Hormone-Stimulated Adenylate Cyclase Activity In Man: Studies With Peripheral Models

  • R. P. Ebstein
  • D. Seiinger
  • J. Mintzer
  • G. Oppenheim
  • L. R. Goldin
  • B. S. Ebstein
  • O. Brawman
  • Z. Shemesh
  • J. Stessman
Part of the Advances in Behavioral Biology book series (ABBI, volume 29)

Abstract

Cyclic AMP, the so-called “second messenger” mediates the effects of a number of hormones including catecholamines on a plethora of cell processes (1). The hormone-stimulated adenylate cyclase complex consists of three principal components. The receptor spans the plasma membrane and its external side provides a site for binding circulating hormones. The Ns and Ni proteins, or guanine-nucleotide binding regulatory subunits, link the receptor to the catalytic subunit of the enzyme. Ihe activated or inhibited (in the case of Ni coupling) catalytic subunit converts ATP to cyclic AMP. The various components of the hormone-sensitive adenylate cyclase complex can to sane extent be separately measured and a number of studies have demonstrated the functional independence of these subunits (2).

Keywords

Dementia Prostaglandin Epinephrine Catecholamine Glucagon 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    E.W. Sutherland, I. Oye, and R.W. Butcher, Ree. Prog. Hormone Res, 21: 623 (1965).Google Scholar
  2. 2.
    G.L. Giles, M.G. Caron and R.J. Lefkowitz, Physiol. Rev. 64: 661 (1984)Google Scholar
  3. 3.
    J. Stessman, R. Eliakim, C. Cahan, and R.P. Ebstein, J. Gerontol. 39: 667 (1984).PubMedGoogle Scholar
  4. 4.
    J. Stessman, R. Eliakim, and R.P. Ebstein, Age, 7: 71 (1984).CrossRefGoogle Scholar
  5. 5.
    M. Newman, E. Klein, B. Birmaher, M. Feinsod, and R.H. Belmaker, Brain Res. 278: 380 (1983).PubMedCrossRefGoogle Scholar
  6. 6.
    D. Seiinger, D. Waksman, J. Stessman, and R.P. Ebstein, Salbutamol- induced rise in cyclic AMP and amylase levels in human parotid secretion, submitted.Google Scholar
  7. 7.
    R.P. Ebstein, J.Biederman, R. Rimon, J. Zohar, and R.H. Belmaker, Psychopharmacol. 51: 71 (1976).Google Scholar
  8. 8.
    R.P. Ebstein, G. Oppenheim, and J. Stessman, Life Sei. 34: 2239 (1984).CrossRefGoogle Scholar
  9. 9.
    Oppenheim, G., J. Mintzer, I. Halperin, R. Eliakim, J. Stessman and R.P. Ebstein, Life Sei. 35: 1795 (1984).CrossRefGoogle Scholar
  10. 10.
    R.P. Ebstein, G. Oppenheim, M.S. Tropper, A. Yagur, and J. Stessman, Clin. Neuropharmacol. 7 (Suppl.l): S23 (1984).Google Scholar
  11. 11.
    N.S. Nadi, J.I. Nürnberger, Jr., and E.S. Gershon, New Engl. J. Med. 311: 225 (1984).Google Scholar
  12. 12.
    R.P. Ebstein, M. Steinitz, J. Mintzer, J., I. Lipshitz, and J. Stessman, Beta-adrenergic stimulated adenylate cyclase activity in normal and EBV-transformed lymphocytes, submitted.Google Scholar
  13. 13.
    J. Mintzer, O. Brawman, I. Lipshitz, Z. Shemesh, J. Stessman, and R.P. Ebstein, Hormone and forskolin-stimulated cyclic AMP accumulation in human lymphocytes: Reliability of longitudinal measurements, submitted.Google Scholar
  14. 14.
    R.P. Ebstein, J. Mintzer, Y. Lipschitz, Z. Shemesh, L.R. Goldin, and J. Stessman, Heritability of forskolin and hormone-stimulated adenylate cyclase activity in human lymphocytes, submitted.Google Scholar
  15. 15.
    R.P. Ebstein, 0. Brawman, J. Mintzer, B.S. Ebstein and J. Stessman, Hormone-stimulated cyclic AMP synthesis in human lymphocytes during the menstrual cycle, submitted.Google Scholar
  16. 16.
    J.H. Ball, N.I. Kaminsky, J.G. Hardman, A.E. Broadus, E.W. Sutherland, and G.W. Liddle, J. Clin. Invest. 51: 2124 (1972).PubMedCrossRefGoogle Scholar
  17. 17.
    R.P. Ebstein, T. Kara, and R.H. Belmaker, Acta Pharmacol. Toxicol. 41: 80 (1977).CrossRefGoogle Scholar
  18. 18.
    I.D. Mandel and R.L. Katz, J. Oral Ther. Pharmacol. 4: 260 (1968).PubMedGoogle Scholar
  19. 19.
    D. Selinger, D.J. Cohen, S. Ort, G.M. Anderson, K.A. Caruso and J.F. Leckman, J. Am. Acad. Child Psychiatry, 23: 392 (1984).PubMedCrossRefGoogle Scholar
  20. 20.
    C.S. Henney, H.R. Bourne, and L.M. Lichtenstein, J. Immunol. 108: 1526 (1972).PubMedGoogle Scholar
  21. 21.
    R.L. Walford, J. Gerontol. 17: 281 (1962).Google Scholar
  22. 22.
    D. Cohen and C. Eisdorfer, Br. J. Psychiat. 136: 33 (1980).CrossRefGoogle Scholar
  23. 23.
    J.F. Krall, M. Connelly, and M.L. Tuck, J. Pharmacol. Exp. Ther. 214: 554 (1980).PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1986

Authors and Affiliations

  • R. P. Ebstein
    • 1
  • D. Seiinger
    • 1
  • J. Mintzer
    • 1
  • G. Oppenheim
    • 1
  • L. R. Goldin
    • 1
  • B. S. Ebstein
    • 1
  • O. Brawman
    • 1
  • Z. Shemesh
    • 1
  • J. Stessman
    • 1
  1. 1.Department of Geriatrie ResearchEzrath Nashim Hospital JerusalemIsrael

Personalised recommendations